Biotech

Latest Articles

Former Seagen chief executive officer introduces new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2014 for an immens...

Ironwood makes more bid for $1B GI medicine with brand-new subgroup records

.On the heels of a stage 3 succeed that failed to blow away financiers, Ironwood Pharmaceuticals is ...

Novartis inks $150M bargain for autoimmune molecular glue

.Do not quit Monte Rosa Therapies now. The Boston-based biotech is actually enjoying after authorizi...

Jade carves out exec team with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of significant management hirings, firings and ...

Septerna goes social along with upsized offering of $288M

.Celebrating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fine...

AbbVie makes Richter richer, paying for $25M to make up finding pact

.AbbVie has gone back to the source of its antipsychotic goliath Vraylar searching for yet another r...

GenSight enters ultimate full weeks of cash runway as earnings flow squeezes by of grasp

.GenSight Biologics is actually weeks off of losing loan. Once again. The biotech merely possesses e...

AZ licenses thrown away rare health condition medicine to Monopar Therapeutics

.Monopar Therapies is recuperating a medication coming from the scrap heap of AstraZeneca's uncommon...

Arcus' brand-new HIF-2a data in renal cancer cells hint at potential advantage over Merck's Welireg, analysts claim

.With brand-new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of analysts ...

Roche bets as much as $1B to expand Dyno genetics treatment distribution contract

.After creating a gene therapy partnership with Dyno Rehabs in 2020, Roche is actually back for more...

Lundbeck slashes value of $250M Abide acquistion after discomfort obstacle

.Lundbeck is actually slashing the book value of its $250 thousand Abide Therapies buyout in respons...

Real- Globe Information Meets Clinical Trial Design: Enhancing Procedures as well as Internet Site Assortment

.The assimilation of real-world records (RWD) in to protocol usefulness and also internet site colle...

Where are they presently? Overtaking past Fierce 15 honorees

.At this year's Intense Biotech Peak in Boston, our experts overtook leaders in the biotech industry...

Merck purchases preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually taking down $30 thousand ahead of time to get Yale spinout Modifi Biosci...

Radiopharma Alpha-9 elevates $175M collection C to money clinical press

.Alpha-9 Oncology has actually increased a $175 thousand series C round to money its own clinical-st...

Ocuphire to completely transform in to genetics treatment biotech by means of Opus buyout

.Eye medication creator Ocuphire Pharma is obtaining genetics therapy programmer Piece Genetics in a...

Roche culls cough candidate, turns KRAS system in Q3 update

.Roche's chronic cough course has actually faltered to a stop. The drugmaker, which axed the system ...

Merck- Gilead long-acting oral combo reduces HIV for 48 full weeks

.Gilead Sciences and Merck &amp Co. have actually assisted their once-weekly HIV mix therapy past ye...

Lykos allows FDA look at that MDMA authorization relies upon fresh trial

.Lykos Rehabs may possess shed three-quarters of its staff back the FDA's turndown of its own MDMA c...

Septerna considers $158M IPO to money readouts for GPCR pipeline

.Septerna may be actually as yet to reveal "any sort of meaningful medical information," however the...